Global Vaccine Adjuvants Market: Overview
Adjuvants are basically compounds that improve the body’s immunogenic reaction against antigens. Therefore, adjuvants are majorly added to vaccines to augment their capability to persuade long-term protection and safety against any kind of infections. Vaccine adjuvants are in the method of advancement and currently, MF59 and aluminum salts are the only adjuvants which are feasible for human usage.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Global Vaccine Adjuvants Market: Growth Factors
The vaccine adjuvants are majorly driven by the aspects such as the high occurrence of zoonotic and infectious syndromes, long-lasting vaccination, growing focus on improved and emerging syndrome. Different government bodies are majorly focusing on immunization schemes which are also projected to fuel the demand and requirement for vaccine adjuvants. The significance of adjuvant examination in vaccine expansion has increased considerably owing to the restricted immunogenicity of novel and new vaccine antigens. Few vaccines have novel adjuvant formulations that are regularly reaching development stages thus offering the latest equipment to fill former unmet clinical needs. On the other hand, several adjuvants fail at the time of product development owing to the aspects such as stability, lack of effectiveness, safety concerns, unacceptable levels of tolerability, or manufacturability. The growing usage of synthetic vaccines and recombinant sub-unit also anticipate fuelling the global vaccine adjuvants market in the coming years.
Global Vaccine Adjuvants Market: Segmentation
The global vaccine adjuvants market is fragmented into the route of administration, product type, applications, disease type, and application categories. In terms of product type, the global vaccine adjuvants market is classified into adjuvant emulsions, pathogen components, combination adjuvants, particulate adjuvants, and others. In terms of route of administration, the global vaccine adjuvants market is divided into subcutaneous, intranasal, oral, intradermal, intramuscular, and others. In terms of disease type, the global vaccine adjuvants market comprises cancer, infectious diseases, and other diseases. The infectious diseases division is projected to account for the highest market share of the global market. Research investments in life sciences and the increase in the occurrences of diseases are the most important aspects fuelling the development of this segment. In terms of applications, the global vaccine adjuvants market is fragmented into commercial and research applications. In terms of application categories, the global vaccine adjuvants market is categorized into veterinary and human adjuvants.
Global Vaccine Adjuvants Market: Regional Analysis
Europe is likely to be the largest market for the global vaccines adjuvants on the basis of revenue and is projected to continue to lead the market owing to the growing occurrences of diseases, for instance, infections and cancer. The global vaccine adjuvants market is projected to grow considerably in North America since FDA is expected to add few of adjuvant which contains vaccines, particularly in their stockpile. Asia Pacific & Africa is anticipated to be the largest increasing vaccine adjuvants global market in the coming years owing to growing occurrence of HIV, cancer, hepatitis, influenza, and others.
Global Vaccine Adjuvants Market: Competitive Players
Some of the most important market players in the global vaccine adjuvants market are OZ Biosciences, InvivoGen, SEPPIC, Sigma-Aldrich Co. LLC, Agenus, Inc., SPI Pharma, VaxLiant LLC, Aphios Corp., Kineta, Inc., and Vaxine Pty Ltd., among others.
Global Vaccine Adjuvants Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets